Filing Flows › Parabilis Medicines (PBLS) › Recalls, complaints & regulation
Parabilis Medicines (PBLS): clinical trials
Parabilis Medicines (PBLS) beyond its filings: 1 active clinical trial.
Parabilis Medicines' latest quarter
Parabilis Medicines, Q2 2026: revenue $148K, net loss $52.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Parabilis Medicines have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.